1. Home
  2. AARD vs ZH Comparison

AARD vs ZH Comparison

Compare AARD & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$12.28

Market Cap

281.1M

Sector

Health Care

ML Signal

HOLD

Logo Zhihu Inc. (every two of each representing one ordinary share)

ZH

Zhihu Inc. (every two of each representing one ordinary share)

HOLD

Current Price

$3.45

Market Cap

293.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AARD
ZH
Founded
2017
2011
Country
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
293.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AARD
ZH
Price
$12.28
$3.45
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$31.11
N/A
AVG Volume (30 Days)
148.5K
300.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.97
Revenue Growth
N/A
N/A
52 Week Low
$4.88
$3.23
52 Week High
$19.58
$6.32

Technical Indicators

Market Signals
Indicator
AARD
ZH
Relative Strength Index (RSI) 43.27 43.61
Support Level $11.14 $3.41
Resistance Level $13.58 $3.76
Average True Range (ATR) 1.05 0.18
MACD -0.14 -0.02
Stochastic Oscillator 31.45 17.65

Price Performance

Historical Comparison
AARD
ZH

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.

Share on Social Networks: